Lung cancer in patients with HIV infection: is it AIDS-related?

被引:22
作者
Burke, M
Furman, A
Hoffman, M
Marmor, S
Blum, A
Yust, I
机构
[1] Tel Aviv Sourasky Med Ctr, Clin Immunol Unit, Kobler Crusaid Ctr, IL-64239 Tel Aviv, Israel
[2] Tel Aviv Sourasky Med Ctr, Dept Med A, IL-64239 Tel Aviv, Israel
[3] Tel Aviv Sourasky Med Ctr, Dept Pathol, IL-64239 Tel Aviv, Israel
[4] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
关键词
HAART; HIV; lung cancer; non-AIDS-defining tumours;
D O I
10.1111/j.1468-1293.2004.00196.x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
HIV-infected individuals have an increased risk of malignancy, especially non-Hodgkin's lymphoma and Kaposi's sarcoma. Recently, several workers have noted a raised prevalence of lung cancer in HIV-positive subjects. We describe the diagnosis and clinical course for four HIV-seropositive patients who presented with lung cancer. All of the patients were young and were heavy smokers. They were all on highly active antiretroviral therapy (HAART), although the adherence varied from poor to excellent. The CD4 cell counts of these patients ranged from 200 to 686 cells/muL and their viral loads ranged from undetectable to 29 000 HIV-1 RNA copies/mL. After initial diagnosis of HIV infection between 5 and 13 years previously, they all presented with advanced lung cancer, with a very short clinical course, and all four died within 2-9 months of diagnosis. A comparison of the incidence of lung cancer in patients with HIV infection at our centre with that in the general population suggests that there is an increased prevalence in the HIV-infected patients. We review the literature and discuss whether lung cancer in HIV infection is coincidental or related to the primary disease.
引用
收藏
页码:110 / 114
页数:5
相关论文
共 40 条
[1]  
Appleby P, 2000, JNCI-J NATL CANCER I, V92, P1823, DOI 10.1093/jnci/92.22.1823
[2]  
Beck James M., 2001, American Journal of Respiratory and Critical Care Medicine, V164, P2120
[3]   CANCER RISK AFTER RENAL-TRANSPLANTATION IN THE NORDIC COUNTRIES, 1964-1986 [J].
BIRKELAND, SA ;
STORM, HH ;
LAMM, LU ;
BARLOW, L ;
BLOHME, I ;
FORSBERG, B ;
EKLUND, B ;
FJELDBORG, O ;
FRIEDBERG, M ;
FRODIN, L ;
GLATTRE, E ;
HALVORSEN, S ;
HOLM, NV ;
JAKOBSEN, A ;
JORGENSEN, HE ;
LADEFOGED, J ;
LINDHOLM, T ;
LUNDGREN, G ;
PUKKALA, E .
INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (02) :183-189
[4]   HIV-related lung cancer in the era of highly active antiretroviral therapy [J].
Bower, M ;
Powles, T ;
Nelson, M ;
Shah, P ;
Cox, S ;
Mandelia, S ;
Gazzard, B .
AIDS, 2003, 17 (03) :371-375
[5]   LUNG-CANCER IN PATIENTS SEROPOSITIVE FOR HUMAN-IMMUNODEFICIENCY-VIRUS [J].
BRAUN, MA ;
KILLAM, DA ;
REMICK, SC ;
RUCKDESCHEL, JC .
RADIOLOGY, 1990, 175 (02) :341-343
[6]  
Brockmeyer N, 1998, Eur J Med Res, V3, P127
[7]  
BROWN B, 2003, 10 C RETR OPP INF BO
[8]   Pulmonary malignancies in the immunocompromised patient [J].
Cadranel, J ;
Naccache, JM ;
Wislez, M ;
Mayaud, C .
RESPIRATION, 1999, 66 (04) :289-309
[9]   Reduced incidence of Kaposi's sarcoma and of systemic non-Hodgkin's lymphoma in HIV-infected individuals treated with highly active Antiretroviral therapy [J].
Carrieri, MP ;
Pradier, C ;
Piselli, P ;
Piche, M ;
Rosenthal, E ;
Heudier, P ;
Durant, J ;
Serraino, D .
INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (01) :142-144
[10]   HIV-related malignancies: community-based study using linkage of cancer registry and HIV registry data [J].
Cooksley, CD ;
Hwang, LY ;
Waller, DK ;
Ford, CE .
INTERNATIONAL JOURNAL OF STD & AIDS, 1999, 10 (12) :795-802